You are here: Industry Insights > Novartis

News List

Novartis links with NHS Cancer Vanguard sites pharmatimes
March 22, 2018
Swiss drug giant Novartis has announced the launch of two new joint working projects with national Cancer Vanguard sites, which aim to determine novel ways of boosting patient care pathways and access to services.
Novartis steps into the medical marijuana business pharmafile
March 21, 2018
Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player.
Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis biospace
March 21, 2018
The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A
Treatment with Novartis' Ultibro® Breezhaler® improved cardiac function in COPD patients with lung h worldpharmanews
March 13, 2018
Novartis today announced the publication of the CLAIM* study in the Lancet Respiratory Medicine
Novartis expands alliance with Science 37 to advance virtual clinical trials program worldpharmanews
March 12, 2018
Novartis has announced an additional strategic alliance with Science 37, a leader in decentralized clinical trial technology and design, to initiate up to 10 new clinical trials over the next three years.
Novartis’ Xolair backed in global urticaria guidelines pharmatimes
March 07, 2018
Novartis’ Xolair has been recommended in global guidelines for treating chronic spontaneous urticaria in patients unresponsive to antihistamines.
Novartis to develop digital therapies with Pear pharmaphorum
March 06, 2018
Novartis has joined with one of the rising stars in digital health, Pear Therapeutics, to develop digital therapeutics for patients with schizophrenia and multiple sclerosis.
Novartis forms a Pear to develop mobile therapies pharmafile
March 05, 2018
Novartis has announced an agreement between Pear Therapeutics and itself to develop two digital therapeutics, one in schizophrenia and one in multiple sclerosis (MS).
Novartis cancer chief joins biotech startup as CMO biospectrumasia
March 01, 2018
Peng was the global head of oncology translational medicine at Shanghai CNIBR (China Novartis Institutes for BioMedical Research).
Treatment with Novartis' Ultibro® Breezhaler® improved cardiac function in COPD patients with lung h worldpharmanews
February 28, 2018
Novartis today announced the publication of the CLAIM* study in the Lancet Respiratory Medicine

Previous page 1 2 3 4 5 6 7 8 9 10 ... 71 72 Next page